Cure8

Why This Matters

The study identifies Piezo1 in intestinal epithelial cells as a potential driver of intestinal fibrosis in IBD via a stiffness → ROS → partial EMT pathway, and suggests targeting Piezo1 or ROS could reduce fibrosis in preclinical models.

Who Should Pay Attention

Researchers studying IBD fibrosis mechanisms, clinicians interested in fibrosis complications of IBD, and translational scientists exploring anti-fibrotic therapies.

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract

What To Know

The research uses DSS-induced fibrosis models, human IBD patient samples, and IEC-specific Piezo1 knockout mice to show Piezo1 is upregulated in fibrotic intestinal regions and that IEC-specific loss of Piezo1 reduced fibrosis without substantially changing chronic inflammation markers or fibroblast proliferation.

Mechanistic data from RNA-sequencing, metabolic assays, and stiffness-gradient hydrogels suggest Piezo1 activation by a stiffer matrix increases intracellular Ca2+ and reactive oxygen species, promoting a partial EMT in IECs.

Piezo1 knockout or antioxidant treatment (vitamin C) prevented these stiffness-induced changes in vitro, and high-dose oral vitamin C reduced fibrosis in vivo in the models used.

Keep In Mind

Results are from preclinical models (DSS mouse model, IEC-specific knockout mice, human tissue expression data, and in vitro stiffness assays). Abstract-level summary only; clinical relevance requires further study and human trials.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationJournal of Crohn's & colitis
AuthorsXinghuang Liu, Ruohang He, Zhiyue Xu +7 more
InstitutionDivision of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, PR China.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedSep 3, 2026, 12:00 AM
Content availableJournal abstract

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →